Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free CINGW Stock Alerts

Cingulate (CINGW) Competitors

$0.0051 0.00 (-1.94%)
As of 10/2/2026 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

CINGW vs. SXTPW, BFRIW, CLVR, CMRAW, and CDTTW

Should you buy Cingulate stock or one of its competitors? Cingulate's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Clever Leaves (CLVR), Comera Life Sciences (CMRAW), and Conduit Pharmaceuticals (CDTTW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Cingulate compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Cingulate Neutral

Summary

60 Degrees Pharmaceuticals beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Cingulate N/A N/A N/A

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Cingulate Neutral

Summary

Biofrontera beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Clever Leaves?

Cingulate (NASDAQ:CINGW) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

Cingulate has higher earnings, but lower revenue than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
Cingulate Neutral
Clever Leaves Neutral

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Clever Leaves N/A N/A N/A

Summary

Clever Leaves beats Cingulate on 3 of the 3 factors compared between the two stocks.

How does Cingulate compare to Comera Life Sciences?

Cingulate (NASDAQ:CINGW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Cingulate Neutral
Comera Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Comera Life Sciences N/A N/A N/A

Summary

Comera Life Sciences beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Conduit Pharmaceuticals?

Conduit Pharmaceuticals (NASDAQ:CDTTW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Conduit Pharmaceuticals had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for Conduit Pharmaceuticals and 0 mentions for Cingulate. Conduit Pharmaceuticals' average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Conduit Pharmaceuticals Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Conduit Pharmaceuticals beats Cingulate on 1 of the 1 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

Export
MetricCingulatePharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.24B$7.16B$13.28B
Dividend YieldN/A2.64%2.54%17.32%
P/E RatioN/A799.70275.6626.04
Price / SalesN/A752.92609.4691.89
Price / CashN/A86.6678.8752.62
Price / BookN/A10.4610.936.31
Net IncomeN/A$2.84B$3.51B$362.16M
7 Day PerformanceN/A-1.57%-2.00%-1.66%
1 Month PerformanceN/A-5.67%-6.15%-4.50%
1 Year PerformanceN/A-4.73%7.44%2.06%

Cingulate Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.01
-1.9%		N/A-92.3%$0.00N/AN/A14
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-30.1%$0.00$1.11MN/A3
BFRIW
Biofrontera
N/A$0.02
+11.1%		N/A-83.8%$0.00$46.18MN/A94
CLVR
Clever Leaves
N/A$0.00
-50.0%		N/AN/A$0.00$17.42MN/A560
CMRAW
Comera Life Sciences
N/AN/AN/AN/A$0.00$1.00MN/A2

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CINGW) was last updated on 10/3/2026 by MarketBeat.com Staff.
From Our Partners
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel